CD8A and neoplasm: TGF-B then constrains Th1 response and M1-type macrophage activity; suppresses lymphocytes CD8+, natural killer (NK) cells, and dendritic cell (DC) function; generates Treg with immunosuppressive function; and promotes M2-type macrophages with pro-tumor activity [19,20].